Autres langues Granules India Limited NSE India S.E.

Actions

GRANULES

INE101D01020

Temps Différé NSE India S.E. Autres places de cotation 05:48:37 30/04/2024			Varia. 5j.	Varia. 1 janv.
423 ^INR	+0,61 %		+2,05 %	+4,33 %

03/04	L'unité indienne de Granules obtient le statut VAI pour son site de Virginie	MT
02/04	Granules India Limited annonce la nomination d'administrateurs	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	15/04
Granules India Unit Gets VAI Status for Virginia Facility	03/04
Granules India Limited Announces Appointment of Directors	02/04
Granules India Limited Announces Cessation of Arun Rao Akinepally as Independent Director	29/03
Granules India Limited Announces Appointment of Sethu Madhavan Sankaran as Senior Vice President - Api Manufacturing & Operations	29/03
Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer	11/03
Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing	05/03
Paracetamol maker Granules India posts marginal rise in Q3 profit	23/01
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit	23/01
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA	18/12
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets	13/12
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets	13/12
Granules India Arm Gets US FDA Nod for Sildenafil for Oral Suspension	04/12
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	09/11
Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Granules India : Received ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules	19/10/23
Granules India Gets US FDA's Approval for Generic Drug for GERD Symptoms	19/10/23
Granules India Limited Receives ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules	19/10/23
Indian paracetamol maker Valiant Laboratories lists at 16% premium	06/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Granules India Limited NSE India S.E.

Actions

GRANULES

INE101D01020

Autres langues

Filtres